In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria
暂无分享,去创建一个
Said Ghalem | Imane Abdelli | Faiçal Hassani | Sohayb Bekkel Brikci | S. Ghalem | F. Hassani | I. Abdelli | Sohayb Bekkel Brikci
[1] Kemal Yelekçi,et al. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes , 2020, Journal of biomolecular structure & dynamics.
[2] Bikash Medhi,et al. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain) , 2020, Journal of biomolecular structure & dynamics.
[3] Vladimir Poroikov,et al. PASS: prediction of activity spectra for biologically active substances , 2000, Bioinform..
[4] J J Baldwin,et al. Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.
[5] L. Trabut. Flore du Nord de l'Afrique, répertoire des noms indigènes des plantes spontanées, cultivées et utilisées dans le Nord de l'Afrique , 1935 .
[6] Ramakrishna Vadde,et al. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel , 2020, Journal of biomolecular structure & dynamics.
[7] Z. Memish,et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China , 2020, International Journal of Infectious Diseases.
[8] Arthur M. Lesk,et al. Introduction to Protein Science: Architecture, Function, and Genomics , 2001 .
[9] M. Swierczewska,et al. What is the future of PEGylated therapies? , 2015, Expert opinion on emerging drugs.
[10] Alex M Aronov,et al. Predictive in silico modeling for hERG channel blockers. , 2005, Drug discovery today.
[11] L. Benet,et al. The Operational Multiple Dosing Half-life: A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage Forms , 2008, Pharmaceutical Research.
[12] Rajat Kumar Jha,et al. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase , 2020, Journal of biomolecular structure & dynamics.
[13] Enrique S. Quintana-Ortí,et al. iMODS: internal coordinates normal mode analysis server , 2014, Nucleic Acids Res..
[14] M. Bouachrine,et al. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations , 2020, Journal of biomolecular structure & dynamics.
[15] M. Michael Gromiha,et al. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19 , 2020, Journal of biomolecular structure & dynamics.
[16] T. Velavan,et al. The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.
[17] I. Muegge,et al. Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.
[18] S. Harrison,et al. Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.
[19] Ayesha Obaid,et al. Mutation-Structure-Function Relationship Based Integrated Strategy Reveals the Potential Impact of Deleterious Missense Mutations in Autophagy Related Proteins on Hepatocellular Carcinoma (HCC): A Comprehensive Informatics Approach , 2017, International journal of molecular sciences.
[20] Maurizio Guastalegname,et al. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment? , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] S. Pole. Ayurvedic Medicine: The Principles of Traditional Practice , 2006 .
[22] Klaus Slenzka,et al. Fundamentals of space biology : research on cells, animals, and plants in space , 2006 .
[23] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[24] P. V. Balaji,et al. Monomerization alters the dynamics of the lid region in Campylobacter jejuni CstII: an MD simulation study , 2016, Journal of biomolecular structure & dynamics.
[25] A. Mishra,et al. Evaluation of some essential oils against dermatophytes. , 1990 .
[26] Majid Sharifi,et al. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin , 2020, Journal of biomolecular structure & dynamics.
[27] Klaus Slenzka,et al. Fundamentals of Space Biology , 2006 .
[28] R. Smalling. Molecular biology of plasminogen activators: what are the clinical implications of drug design? , 1996, The American journal of cardiology.
[29] J. Stewart. Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements , 2007, Journal of molecular modeling.
[30] Hemant Kumar Srivastava,et al. Peptide-like and small-molecule inhibitors against Covid-19 , 2020, Journal of biomolecular structure & dynamics.
[31] Sanjay Joshua Swamidass,et al. RS-WebPredictor: a server for predicting CYP-mediated sites of metabolism on drug-like molecules , 2013, Bioinform..
[32] David E. Shaw,et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..
[33] B. M. Lawrence. Progress in Essential Oils , 2009 .
[34] A. Elfiky,et al. Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective , 2020, Journal of biomolecular structure & dynamics.
[35] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[36] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[37] Reaz Uddin,et al. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach , 2020, Journal of biomolecular structure & dynamics.
[38] Joseph Casanova,et al. Isothymol in Ajowan Essential Oil , 2010, Natural product communications.
[39] Olivier Michielin,et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.
[40] M. Boskabady,et al. Inhibitory effect of Carum copticum on histamine (H1) receptors of isolated guinea-pig tracheal chains. , 2000, Journal of Ethnopharmacology.
[41] Pablo Chacón,et al. iMod: multipurpose normal mode analysis in internal coordinates , 2011, Bioinform..
[42] F. Sandberg,et al. Natural Remedies: Their Origins and Uses , 2001 .
[43] N. Kambouche,et al. Composition of the Volatile Oil from the Aerial Parts of Trachyspermum ammi (L.) Sprague from Oran (Algeria) , 2003 .
[44] P. Davoodian,et al. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study , 2020, Journal of biomolecular structure & dynamics.
[45] Adolfo B Poma,et al. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment , 2020, Journal of biomolecular structure & dynamics.
[46] K. Srinivasan,et al. In Silico Drug-Designing Studies on Flavanoids as Anticolon Cancer Agents: Pharmacophore Mapping, Molecular Docking, and Monte Carlo Method-Based QSAR Modeling , 2017, Interdisciplinary Sciences: Computational Life Sciences.
[47] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.